• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Influenza Other Respir Viruses . Antigenic Variation and Immune Recognition Inference From the COVID-19 Pandemic: An In Silico Comparative Analysis

tetano

Editor, Senior Moderator
Influenza Other Respir Viruses


. 2026 Jul;20(7):e70286.
doi: 10.1111/irv.70286.
Antigenic Variation and Immune Recognition Inference From the COVID-19 Pandemic: An In Silico Comparative Analysis of Spike T Cell Epitopes From the SARS-CoV-2 Variants of Concern

Katherine L Li[SUP] 1 2 [/SUP], Paul Sandstrom[SUP] 1 2 [/SUP], Hezhao Ji[SUP] 1 2 [/SUP]


Affiliations
Abstract

Background: With increased transmission but reduced disease severity, the Omicron SARS-CoV-2 variants have contributed to the multifaceted transition of COVID-19 from a global pandemic to an endemic disease. Nonetheless, the persistence of hypermutable viral variants and their ability to infect both vaccinated and previously infected individuals raise concerns about continued viral evolution and immune evasion.
Methods: This study employs comprehensive in silico analyses to compare the five former variants of concern (VOCs) to elucidate their T cell antigenic variations in relation to human leukocyte antigen (HLA) recognition and binding.
Results: Our major histocompatibility complex (MHC) class I and II epitope predictions suggest that the Omicron BA.1 variant harbors more putative epitopes than other VOCs (2.0-11.0 times more). Moreover, the distribution of predicted MHC-II epitopes across HLA alleles differs substantially, with Omicron displaying significant differences from at least three VOCs in all analyses. Investigation of HLA-epitope binding affinities indicates that Omicron epitopes often exhibit enhanced HLA binding compared with the Wuhan Reference (57.8%, 81.8%, and 60.0% of MHC-I, MHC-II regular, and MHC-II promiscuous pairs, respectively), which could influence immune responses.
Conclusions: These findings reveal marked differences in the putative epitope profiles of Omicron BA.1 and the Wuhan Reference, as well as other pre-Omicron VOCs, highlighting its altered HLA recognition status. Given the continued transmission and emergence of new SARS-CoV-2 lineages, this study highlights the importance of ongoing research to understand the evolutionary dynamics of high-risk SARS-CoV-2 variants, their host immune system interactions, and the downstream implications in vaccine and therapeutic development.

Keywords: SARS‐CoV‐2; T cell epitope; antigenic variation; computational biology; immune recognition; variants of concern.

 
Back
Top